Aadil Khan
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer Cells and Metastasis
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
Papers in
- Co-authors
- Kevin J. HarringtonJames PagetHolly E. BarkerJoan KyulaN J McC MortensenM G W KettlewellJ. M. D. WheelerDavid Mansfield
- Journals
- Journal of Plastic Reconstructive & Aesthetic Surgery (7 papers)British journal of surgery (4 papers)European Journal of Surgical Oncology (3 papers)Plastic & Reconstructive Surgery (3 papers)The Breast (3 papers)
- Partner nations
- United KingdomUnited StatesIndia
In The Last Decade
Aadil Khan
72 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Oncology 1.1k
- Cancer Research 450
- Immunology 426
- Biotechnology 147
- Pulmonary and Respiratory Medicine 531
Countries citing papers authored by Aadil Khan
This map shows the geographic impact of Aadil Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aadil Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aadil Khan more than expected).
Fields of papers citing papers by Aadil Khan
This network shows the impact of papers produced by Aadil Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aadil Khan. The network helps show where Aadil Khan may publish in the future.
Co-authors
The 25 scholars most cited alongside Aadil Khan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 0 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 3 | |
| 12 | 2023 | 2 | |
| 13 | 2022 | 2 | |
| 14 | 2022 | 0 | |
| 15 | 2021 | 0 | |
| 16 | 2020 | 10 | |
| 17 | 2019 | 23 | |
| 18 | 2019 | 15 | |
| 19 | 2018 | 17 | |
| 20 | 2010 | 5 |
About Aadil Khan
Aadil Khan is a scholar working on Surgery, Oncology, Biotechnology, Cancer Research and Virology, having authored 90 papers that have together received 2.6k indexed citations. Recurring topics across this work include Virus-based gene therapy research (13 papers), Breast Implant and Reconstruction (11 papers), Reconstructive Surgery and Microvascular Techniques (10 papers), Breast Cancer Treatment Studies (8 papers), Cancer Research and Treatments (6 papers), CAR-T cell therapy research (6 papers), Lymphatic System and Diseases (4 papers) and Diagnosis and Treatment of Venous Diseases (4 papers). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (450 citations), Immunology (426 citations), Biotechnology (147 citations) and Pulmonary and Respiratory Medicine (531 citations). Aadil Khan has collaborated with scholars based in United Kingdom, United States and India. Frequent co-authors include Kevin J. Harrington, James Paget, Holly E. Barker, Joan Kyula, N J McC Mortensen, M G W Kettlewell, J. M. D. Wheeler, David Mansfield, Bruce George and Chris Cunningham. Their work appears in journals such as Journal of Plastic Reconstructive & Aesthetic Surgery, British journal of surgery, European Journal of Surgical Oncology, Plastic & Reconstructive Surgery and The Breast.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.